tirzepatide 日本 Mounjaro injection 15mg 5mg 10mg austria JAPAN Delivery, 7.5 mg at ₹ 3500/vial in New Delhi Eli Lilly's obesity drug crunch

This lets you capture the benefits of GLP-1 agonism at lower cost

Insurance & Access: Your coverage depends heavily on your specific plan

GLP-1 RAs, however, demonstrate superior efficacy in histological resolution of NASH, with a reported relative risk of 2.48 (95% CI: 1.863.30) compared to placebo

For a broader comparison of side effect profiles, our three-way comparison guide covers the key differences

Participants on Zepbound recorded about 25 fewer breathing interruptions per hour (29 in the group also using CPAP), and 42 to 50% ended the year in remission or with mild, symptom-free OSA, according to Lillys trial summary